Volume 21, Number 6—June 2015
CME ACTIVITY - Research
Estimated Deaths and Illnesses Averted During Fungal Meningitis Outbreak Associated with Contaminated Steroid Injections, United States, 2012–2013
Rachel Smith
, Gordana Derado, Matthew Wise, Julie R. Harris, Tom M. Chiller, Martin I. Meltzer, and Benjamin Park
, Gordana Derado, Matthew Wise, Julie R. Harris, Tom M. Chiller, Martin I. Meltzer, and Benjamin Park
Table 2
Meningitis and stroke cases and deaths averted by lot
| Lot no. | Cases averted, no. (95% CI) | Deaths averted, no. (range)* |
|---|---|---|
| 05 | 0 | NA |
| 06 | 53 (32–88) | NA |
| 08 | 100 (29–379) | NA |
| Total | 153 (61–467) | 124 (98–211)† |
*NA, not applicable.
†Total deaths averted (124) derived from total cases averted (153) multiplied by the case fatality rate observed early in the outbreak (28%) plus case-patients who had a diagnosis of meningitis after October 4 and who were alive at 60 days (290) multiplied by the early case fatality rate: (153 × 0.28) + (290 × 0.28). Range derived from the upper and lower confidence intervals of cases averted (e.g., 98 = [61× 0.28] + [290 × 0.28]).
Page created: October 06, 2015
Page updated: October 06, 2015
Page reviewed: October 06, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.